Sulfated glycosaminoglycans inhibit LCMV entry and modulate antiviral immunity and pathology. - Gorzkiewicz M; Noseir S; Vengurlekar M; Ghosh M; Katahira I; Abromavičiūtė D; Gerling-Driessen U; Bonda L; Rähse N; Lapsien M; Bockholt S; Bergmann AK; et al. (EMBO molecular medicine, 2026)